Gallin, Zachary
Kolevzon, Ana M.
Reichenberg, Abraham
Hankerson, Sidney H.
Kolevzon, Alexander http://orcid.org/0000-0001-8129-2671
Article History
Accepted: 8 May 2024
First Online: 28 June 2024
Declarations
:
: AK is on the Advisory Board for the Klingenstein Third Generation Foundation, Ovid Therapeutics, David Lynch Foundation, ADNP Kids Research Foundation, and Ritrova Therapeutics and consults to Acadia, Alkermes, Jaguar Therapeutics, GW Pharmaceuticals, Neuren Pharmaceuticals, Clinilabs Drug Development Corporation, Scioto Biosciences, and Biogen. The remaining authors have no potential conflict of interests related to this publication.